default author photo

Hiroyuki Takei

Saitama Cancer Center

Saitama

Japan

  • Saitama Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

151

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Postoperative Adjuvant Anastrozole for 10 Rather than 5 Years in Patients with Oestrogen Receptor-Positive Breast Cancer: AERAS, a Randomised Multicentre Open-Label Phase III Trial

Number of pages: 44 Posted: 06 Sep 2021
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu and Hirofumi Mukai
Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Fukushima Medical University, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, National Hospital Organization Nagoya Medical Center, University of Tsukuba Hospital/Ibaraki Prefectural Central Hospital, Hirosaki Municipal Hospital, Gunma Prefectural Cancer Center, Saitama Cancer Center, CHO Kurume General Hospital, Sapporo Kotoni Breast Clinic, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Kansai Rosai Hospital, Osaka International Cancer Institute, University of Occupational and Environmental Health, Juntendo University and National Cancer Center Hospital East
Downloads 151 (494,203)

Abstract:

Loading...

hormone receptor positive breast cancer, extended adjuvant endocrine therapy, aromatase inhibitor, late recurrence